FDA Releases Draft Guidance on Medical Device Benefit-Risk Determinations

Summary

The Food and Drug Administration (FDA) has published a draft guidance document outlining factors to consider when evaluating the benefits and risks of medical devices during the premarket review process, aiming to enhance clarity in the agency's decision-making process.